This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Wataru Hirose: Innovator in Anticancer Compounds
Introduction
Wataru Hirose is a notable inventor based in Setagaya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer properties. His work is characterized by a focus on innovative chemical formulations that target specific biological mechanisms.
Latest Patents
Hirose holds a patent for a compound known as a crosslinked optically active secondary amine derivative. This invention, described by the formula (1a), involves a compound that exhibits an anticancer effect by inhibiting the binding between a MLL fusion protein and menin. This mechanism is particularly relevant in the context of MLL leukemia, a type of cancer caused by specific genetic fusions.
Career Highlights
Wataru Hirose is associated with Sumitomo Pharma Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical innovations. His expertise in chemistry and pharmacology has led to breakthroughs that enhance treatment options for cancer patients.
Conclusion
Wataru Hirose's contributions to the field of pharmaceuticals, particularly through his patented inventions, highlight his role as a key innovator in the fight against cancer. His work continues to inspire advancements in medical research and drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile